1 / 11

Cannabis Pharmaceuticals Market Potential Growth, Analysis of Top Key Players

Favorable legislation in the market, policies across developed economies, and investments in the research and development for cannabis-infused drugs are the key factors responsible for the market growth. Moreover, technological innovation to decide the accurate dose of cannabis-infused drugs with cutting edge delivery methods to ensure therapeutic and psychoactive events, to contain drug abuse among adults also favoring market growth for cannabis pharmaceuticals.

priyanka1988
Download Presentation

Cannabis Pharmaceuticals Market Potential Growth, Analysis of Top Key Players

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cannabis Pharmaceuticals Market Market Size Worth $5.72 Billion by 2027 | CAGR: 75.8%

  2. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 “According to Polaris Market Research report, Cannabis Pharmaceuticals market is witnessing a major transformation and is projected to reach $5.72 Billion by 2027 registering a CAGR of 75.8% during the forecast period 2020 to 2027.” The global Cannabis Pharmaceuticals market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Cannabis Pharmaceuticals market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Cannabis Pharmaceuticals Market Report Scope: The study provides a comprehensive view of the Cannabis Pharmaceuticals market by segmenting it based on Product, Distribution Channel and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Cannabis Pharmaceuticals market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Cannabis Pharmaceuticals Market Analysis: https://www.polarismarketresearch.com/industry-analysis/cannabis-pharmaceuticals-market - 2 -

  3. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 By Product By Distribution Channel By Region •Epidiolex •Marinol •Cesamet •Sativex •Hospital Pharmacies •Online Pharmacies •Retail Pharmacies •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Cannabis Pharmaceuticals Market The global Cannabis Pharmaceuticals market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Cannabis Pharmaceuticals market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Cannabis Pharmaceuticals market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry-analysis/cannabis-pharmaceuticals-market/speak-to- analyst - 3 -

  4. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 Competitive Landscape Leading companies holding significant market shares in the Cannabis Pharmaceuticals market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Cannabis Pharmaceuticals market include GW Pharmaceuticals, AbbVie Inc., Valeant Pharmaceuticals, Insys Therapeutics, Inc., Corbus Pharmaceuticals, Teva Pharmaceutical, Johnson & Johnson, Avicanna, Solvay Pharmaceuticals, Cannabics Pharmaceuticals, Portola Pharmaceuticals, Kao Corporation, Ogeda S.A., Pfizer, and Bristol-Myers Squibb. Request for sample: https://www.polarismarketresearch.com/industry-analysis/cannabis- pharmaceuticals-market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Cannabis Pharmaceuticals Market Insights 4.1.Cannabis Pharmaceuticals – Industry snapshot 4.2.Cannabis Pharmaceuticals Market Dynamics 4.2.1.Drivers and Opportunities - 4 -

  5. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 4.2.1.1. 4.2.1.2. 4.2.2.Restraints and Challenges 4.2.2.1. Shelf life of cannabidiol and cross reactions 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Cannabis Pharmaceuticals Market Industry trends 5.Cannabis Pharmaceuticals Market Assessment by Product 5.1.Key Findings 5.2.Introduction 5.2.1.Global Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 5.3.Sativex 5.3.1.Global Cannabis Pharmaceuticals Market, by Sativex, by Region, 2016 – 2027 (USD Million) 5.4.Epidiolex 5.4.1.Global Cannabis Pharmaceuticals Market, by Epidiolex, by Region, 2016 – 2027 (USD Million) 5.5.Marinol 5.5.1.Global Cannabis Pharmaceuticals Market, by Marinol, by Region, 2016 – 2027 (USD Million) 5.6.Cesamet 5.6.1.Global Cannabis Pharmaceuticals Market, by Cesamet, by Region, 2016 – 2027 (USD Million) 6.Global Cannabis Pharmaceuticals Market, by Distribution Channel 6.1.Key Findings 6.2.Introduction 6.2.1.Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 6.3.Hospital Pharmacies 6.3.1.Global Cannabis Pharmaceuticals Market, by Hospital Pharmacies, By Region, 2016 – 2027 (USD Million) 6.4.Online Pharmacies 6.4.1.Global Cannabis Pharmaceuticals Market, by Online Pharmacies, by Region, 2016 – 2027 (USD Million) Increased use in different therapeutic areas Increased support in the form of clinical evidence - 5 -

  6. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 6.5.Retail Pharmacies 6.5.1.Global Cannabis Pharmaceuticals Market, by Retail Pharmacies, by Region, 2016 – 2027 (USD Million) 7.Cannabis Pharmaceuticals Market Assessment by Geography 7.1.Key findings 7.2.Introduction 7.2.1.Cannabis Pharmaceuticals Market Assessment, By Geography, 2016 – 2027 (USD Million) 7.3.Cannabis Pharmaceuticals Market – North America 7.3.1.North America: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.3.2.North America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.3.3.Cannabis Pharmaceuticals Market – U.S. 7.3.3.1. U.S.: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.3.3.2. U.S.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.3.4.Cannabis Pharmaceuticals Market – Canada 7.3.4.1. Canada: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.3.4.2. Canada.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.Cannabis Pharmaceuticals Market – Europe 7.4.1.Europe: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.2.Europe: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.3.Cannabis Pharmaceuticals Market – UK 7.4.3.1. UK: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.3.2. UK: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.4.Cannabis Pharmaceuticals Market – France 7.4.4.1. France: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.4.2. France: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.5.Cannabis Pharmaceuticals Market – Germany - 6 -

  7. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 7.4.5.1. Germany: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.5.2. Germany: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.6.Cannabis Pharmaceuticals Market – Italy 7.4.6.1. Italy: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.6.2. Italy: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.7.Cannabis Pharmaceuticals Market – Spain 7.4.7.1. Spain: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.7.2. Spain: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.8.Cannabis Pharmaceuticals Market – Netherlands 7.4.8.1. Netherlands: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.8.2. Netherlands: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.4.9.Cannabis Pharmaceuticals Market – Austria 7.4.9.1. Austria: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.4.9.2. Austria: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.Cannabis Pharmaceuticals Market – Asia-Pacific 7.5.1.Asia Pacific: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.5.2.Asia Pacific: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.3.Cannabis Pharmaceuticals Market – China 7.5.3.1. China: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.5.3.2. China: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.4.Cannabis Pharmaceuticals Market – India 7.5.4.1. India: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.5.4.2. India.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.5.Cannabis Pharmaceuticals Market – Malaysia 7.5.5.1. Malaysia: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) - 7 -

  8. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 7.5.5.2. Malaysia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.6.Cannabis Pharmaceuticals Market – Japan 7.5.6.1. Japan: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.5.6.2. Japan: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.7.Cannabis Pharmaceuticals Market – Indonesia 7.5.7.1. Indonesia: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.5.7.2. Indonesia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.5.8.Cannabis Pharmaceuticals Market – South Korea 7.5.8.1. South Korea: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.5.8.2. South Korea.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.6.Cannabis Pharmaceuticals Market – Middle East & Africa 7.6.1.Middle East & Africa: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.6.2.Middle East & Africa.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.6.3.Cannabis Pharmaceuticals Market – Saudi Arabia 7.6.3.1. Saudi Arabia: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.6.3.2. Saudi Arabia.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.6.4.Cannabis Pharmaceuticals Market – UAE 7.6.4.1. UAE: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.6.4.2. UAE: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.6.5.Cannabis Pharmaceuticals Market – Israel 7.6.5.1. Israel: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.6.5.2. Israel: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.6.6.Cannabis Pharmaceuticals Market – South Africa 7.6.6.1. South Africa: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.6.6.2. South Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) - 8 -

  9. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 7.7.Cannabis Pharmaceuticals Market – Latin America 7.7.1.Latin America: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.7.2.Latin America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.7.3.Cannabis Pharmaceuticals Market – Mexico 7.7.3.1. Mexico: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.7.3.2. Mexico.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.7.4.Cannabis Pharmaceuticals Market – Brazil 7.7.4.1. Brazil: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.7.4.2. Brazil.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 7.7.5.Cannabis Pharmaceuticals Market – Argentina 7.7.5.1. Argentina: Cannabis Pharmaceuticals Market, By Product, 2016 – 2027 (USD Million) 7.7.5.2. Argentina.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016 – 2027 (USD Million) 8.Competitive Landscape 8.1.Expansion and Acquisition Analysis 8.1.1.Expansion 8.1.2.Acquisition 8.2.Partnerships/Collaborations/Agreements/Exhibitions 9.Company Profiles 9.1.GW Pharmaceuticals 9.1.1.Company Overview 9.1.2.Financial Performance 9.1.3.Product Benchmarking 9.1.4.Recent Development 9.2.Valeant Pharmaceuticals 9.2.1.Company Overview 9.2.2.Financial Performance 9.2.3.Product Benchmarking 9.2.4.Recent Development 9.3.Insys Therapeutics, Inc. 9.3.1.Company Overview 9.3.2.Financial Performance 9.3.3.Product Benchmarking - 9 -

  10. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 9.3.4.Recent Development 9.4.Corbus Pharmaceuticals 9.4.1.Company Overview 9.4.2.Financial Performance 9.4.3.Product Benchmarking 9.4.4.Recent Development 9.5.Teva Pharmaceutical 9.5.1.Company Overview 9.5.2.Financial Performance 9.5.3.Product Benchmarking 9.5.4.Recent Development 9.6.Avicanna 9.6.1.Company Overview 9.6.2.Financial Performance 9.6.3.Product Benchmarking 9.6.4.Recent Development 9.7.Solvay Pharmaceuticals 9.7.1.Company Overview 9.7.2.Financial Performance 9.7.3.Product Benchmarking 9.7.4.Recent Development 9.8.Sprint Corporation 9.8.1.Company Overview 9.8.2.Financial Performance 9.8.3.Product Benchmarking 9.8.4.Recent Development 9.9.Cannabics Pharmaceuticals 9.9.1.Company Overview 9.9.2.Financial Performance 9.9.3.Product Benchmarking 9.9.4.Recent Development 9.10. Kao Corporation 9.10.1.Company Overview 9.10.2.Financial Performance 9.10.3.Product Benchmarking 9.10.4.Recent Development Access Press Release on Cannabis Pharmaceuticals Market: https://www.polarismarketresearch.com/press-releases/cannabis-pharmaceuticals-market About Polaris Market Research - 10 -

  11. Cannabis Pharmaceuticals Market Size Worth $5.72 Billion by 2027 Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 11 -

More Related